Company Filing History:
Years Active: 2017
Title: Eugen Ullmann: Innovator in Lipophilic Oligonucleotide Technology
Introduction
Eugen Ullmann is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of lipophilic oligonucleotide analogs. His innovative work has implications for drug discovery and cellular transfection.
Latest Patents
Ullmann holds a patent for "Lipophilic oligonucleotide comprising a phosphate glycerol unit containing at least one aliphatic unsaturated carbon bond." This patent describes an oligonucleotide that can be unmodified or modified, consisting of 2-1000 nucleotides in length. The invention includes specific structural formulas that detail the components of the oligonucleotide, emphasizing the importance of aliphatic carbon-carbon double bonds. The application of this technology is particularly relevant for drug discovery and the transfection of cells.
Career Highlights
Eugen Ullmann is associated with Miltenyi Biotec GmbH, a company known for its advancements in biotechnology and cell therapy. His work at Miltenyi Biotec has allowed him to focus on innovative solutions that enhance the efficacy of oligonucleotides in therapeutic applications.
Collaborations
Ullmann has collaborated with notable colleagues such as Romualdus Smicius and Thomas Rockel. These partnerships have contributed to the advancement of research and development in the field of oligonucleotide technology.
Conclusion
Eugen Ullmann's contributions to lipophilic oligonucleotide technology represent a significant advancement in biotechnology. His patent and work at Miltenyi Biotec highlight the potential for innovative solutions in drug discovery and cellular applications.